KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
May 17, 2022 $19.66 $21.01 $19.44 $20.91 1 329 427
May 16, 2022 $19.14 $20.37 $18.75 $19.20 1 178 727
May 13, 2022 $17.82 $19.18 $17.62 $19.17 1 341 547
May 12, 2022 $16.21 $17.63 $16.16 $17.35 1 362 769
May 11, 2022 $17.83 $18.69 $16.49 $16.49 2 207 322
May 10, 2022 $16.16 $18.12 $15.31 $17.89 3 332 105
May 09, 2022 $16.81 $17.03 $14.95 $15.36 2 702 153
May 06, 2022 $18.26 $19.48 $17.19 $17.38 8 446 652
May 05, 2022 $16.67 $16.89 $15.28 $15.64 1 984 488
May 04, 2022 $17.82 $17.82 $16.16 $16.99 2 592 886
May 03, 2022 $18.70 $18.96 $17.51 $17.68 1 447 237
May 02, 2022 $18.55 $19.05 $17.76 $18.77 1 694 682
Apr 29, 2022 $18.90 $19.40 $18.36 $18.46 1 151 609
Apr 28, 2022 $19.41 $19.41 $17.90 $19.04 903 423
Apr 27, 2022 $19.25 $19.76 $18.82 $19.07 815 782
Apr 26, 2022 $19.70 $19.76 $19.12 $19.19 1 446 174
Apr 25, 2022 $19.10 $20.03 $19.01 $19.84 823 840
Apr 22, 2022 $21.11 $21.37 $19.34 $19.49 490 470
Apr 21, 2022 $21.11 $21.40 $19.53 $19.69 1 050 300
Apr 20, 2022 $21.21 $21.71 $20.75 $20.88 1 089 300
Apr 19, 2022 $20.80 $21.87 $20.53 $21.20 1 316 500
Apr 18, 2022 $21.43 $21.43 $20.39 $20.69 1 174 400
Apr 14, 2022 $22.10 $22.20 $21.17 $21.55 934 430
Apr 13, 2022 $22.13 $22.41 $21.16 $22.15 1 353 721
Apr 12, 2022 $22.25 $22.50 $20.69 $21.16 1 543 637
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT